Comparison of 4, 8, and 12 week screening and foot care frequencies in persons in remission: The DIATIME comparative efficacy study – A randomized clinical trial
This trial found superior clinical efficacy in preventing plantar recurrence rates with the 4-weeks screening period compared to 8 and 12 weeks. This trial was registered at Clinicaltrials.gov (identifier ID NCT06143215) within the Unique Protocol ID name of the Diatime randomized controlled clinical trial.
Authors
- Marta García‐Madrid (ORCID: https://orcid.org/0000-0001-7349-7378)
- Mateo López‐Moral (ORCID: https://orcid.org/0000-0001-7342-059X)
- Esther García‐Morales (ORCID: https://orcid.org/0000-0002-3896-7079)
- Yolanda García‐Álvarez (ORCID: https://orcid.org/0000-0003-1424-5087)
- Francisco Javier Álvaro‐Afonso (ORCID: https://orcid.org/0000-0003-4674-3822)
- José Luis Lázaro‐Martínez (ORCID: https://orcid.org/0000-0001-6110-0265)
Institutions
- Universidad Complutense de Madrid (ES)
- Hospital Clínico San Carlos (ES)
- Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (ES)
Publication Details
- Journal
- Diabetes Research and Clinical Practice
- Published
- 2025-10-24
- DOI
- https://doi.org/10.1016/j.diabres.2025.112962
- Citations
- 1
- Primary Topic
- Diabetic Foot Ulcer Assessment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.29
Funders
- Universidad Complutense de Madrid